Recombinant SARS-CoV-2 Spike S1 Subunit Fc Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 10622-CV
Tn5 Insect Cell Expressed
Key Product Details
Source
T. ni (baculovirus)
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Trichoplusia ni, T. ni (baculovirus)-derived sars-cov-2 Spike S1 Subunit protein
SARS-CoV-2 Spike S1 Subunit (Val16-Pro681) Accession # YP_009724390.1 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.30 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Val16
Predicted Molecular Mass
101 kDa
SDS-PAGE
105-118 kDa, under reducing conditions
Activity
Measured by its binding ability in a functional ELISA with Recombinant
Human ACE-2 His-tag
(Catalog #
933-ZN).
Scientific Data Images for Recombinant SARS-CoV-2 Spike S1 Subunit Fc Protein, CF
Recombinant SARS-CoV-2 Spike S1 Subunit Fc Chimera Protein Binding Activity.
Recombinant SARS-CoV-2 Spike S1 Subunit Fc Chimera (Catalog # 10622-CV) binds Recombinant Human ACE-2 His-tag (933-ZN) in a functional ELISA.Recombinant SARS-CoV-2 Spike S1 Subunit Fc Chimera Protein SDS-PAGE.
2 μg/lane of Recombinant SARS-CoV-2 Spike S1 Subunit Fc Chimera Protein (Catalog # 10622-CV) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 105-118 kDa and 200-230 kDa, respectively.Formulation, Preparation and Storage
10622-CV
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Spike S1 Subunit
References
- Wu, F. et al. (2020) Nature 579:265.
- Tortorici, M.A. and D. Veesler (2019). Adv. Virus Res. 105:93.
- Bosch, B.J. et al. (2003). J. Virol. 77:8801.
- Belouzard, S. et al. (2009) Proc. Natl. Acad. Sci. 106:5871.
- Millet, J.K. and G. R. Whittaker (2015) Virus Res. 202:120.
- Yuan, Y. et al. (2017) Nat. Commun. 8:15092.
- Walls, A.C. et al. (2010) Cell 180:281.
- Jiang, S. et al. (2020) Trends. Immunol. https://doi.org/10.1016/j.it.2020.03.007.
- Ortega, J.T. et al. (2020) EXCLI J. 19:410.
- Wrapp, D. et al. (2020) Science 367:1260.
- Tai, W. et al. (2020) Cell. Mol. Immunol. https://doi.org/10.1016/j.it.2020.03.007.
- Okba, N. M. A. et al. (2020). Emerg. Infect. Dis. https://doi.org/10.3201/eid2607.200841.
- Wang, X. et al. (2020) https://doi.org/10.1038/s41423-020-0424-9.
- Wang, K. et al. (2020) bioRxiv https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1.
Long Name
Spike Protein, S1 Subunit
Alternate Names
SARS-CoV-2
UniProt
Additional Spike S1 Subunit Products
Product Documents for Recombinant SARS-CoV-2 Spike S1 Subunit Fc Protein, CF
Product Specific Notices for Recombinant SARS-CoV-2 Spike S1 Subunit Fc Protein, CF
For research use only
Loading...
Loading...
Loading...